Show simple item record

dc.contributor.authorSaiyed, Masnoon
dc.contributor.authorHill, Anne J
dc.contributor.authorRussell, Trevor G
dc.contributor.authorTheodoros, Deborah G
dc.contributor.authorScuffham, Paul
dc.date.accessioned2020-09-01T21:04:19Z
dc.date.available2020-09-01T21:04:19Z
dc.date.issued2020
dc.identifier.issn1357-633X
dc.identifier.doi10.1177/1357633X20948302
dc.identifier.urihttp://hdl.handle.net/10072/396928
dc.description.abstractINTRODUCTION: Geographical barriers and impaired physical mobility among people with Parkinson's disease (PD) hinder their timely access to speech pathology services. We compared the costs of delivering a speech treatment via in-person consultation versus telerehabilitation. METHODS: We used data from a non-inferiority randomised controlled trial delivering the Lee Silverman Voice Treatment (LSVT LOUD®), where patients with dysarthria associated with PD were assigned to either the urban in-person group (N = 16) or the urban online group (N = 15), supplemented with a non-randomised group (regional online; N = 21). We compared costs over a one-month treatment period from a health-system perspective and a patient perspective. RESULTS: The mean treatment costs of both urban online ($1076) and regional ($1206) treatments tended to be slightly higher than urban in-person ($1020) from a health-system perspective. From a patient perspective, the mean treatment cost was $831 in the urban in-person group, $247 in the urban online group and $200 in the regional group. DISCUSSION: LSVT LOUD® may be delivered via telerehabilitation at a slightly higher cost than in-person delivery from a health-system perspective, but it is cost saving from a patient perspective. Telerehabilitation is an economically beneficial alternative for the delivery of the LSVT LOUD® programme in PD patients with speech disorders.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherSAGE Publications
dc.relation.ispartofjournalJournal of Telemedicine and Telecare
dc.subject.fieldofresearchBiomedical engineering
dc.subject.fieldofresearchHealth services and systems
dc.subject.fieldofresearchPublic health
dc.subject.fieldofresearchcode4003
dc.subject.fieldofresearchcode4203
dc.subject.fieldofresearchcode4206
dc.subject.keywordsParkinson’s disease
dc.subject.keywordsTelerehabilitation
dc.subject.keywordscost
dc.subject.keywordsspeech pathology
dc.subject.keywordstelemedicine
dc.titleCost analysis of home telerehabilitation for speech treatment in people with Parkinson's disease
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationSaiyed, M; Hill, AJ; Russell, TG; Theodoros, DG; Scuffham, P, Cost analysis of home telerehabilitation for speech treatment in people with Parkinson's disease, Journal of Telemedicine and Telecare, 2020
dc.date.updated2020-08-31T03:22:55Z
dc.description.versionAccepted Manuscript (AM)
gro.description.notepublicThis publication has been entered in Griffith Research Online as an advanced online version.
gro.rights.copyrightSaiyed, M; Hill, AJ; Russell, TG; Theodoros, DG; Scuffham, P, Cost analysis of home telerehabilitation for speech treatment in people with Parkinson's disease, Journal of Telemedicine and Telecare, 2020. Copyright 2020 The Authors. Reprinted by permission of SAGE Publications.
gro.hasfulltextFull Text
gro.griffith.authorSaiyed, Masnoon
gro.griffith.authorScuffham, Paul A.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record